Last reviewed · How we verify
NCT04183348: EVA
Evaluation of the Effect of a Visio-Hearing Training Protocol on Spatial Hearing in Subjects With Hearing Loss
NA trial testing Training Protocol n°1 first at Visit 1, then, Training Protocol n°2 at Visit 2 in Cochlear Nerve Deafness in 79 participants. Completed in 23 May 2022.
23 May 2022
Quick facts
| Lead sponsor | Hospices Civils de Lyon |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | other |
| Enrollment | 79 |
| Start date | 6 July 2020 |
| Primary completion | 23 May 2022 |
| Estimated completion | 23 May 2022 |
| Sites | 2 locations across France |
Drugs / interventions tested
- Training Protocol n°1 first at Visit 1, then, Training Protocol n°2 at Visit 2
- Training Protocol n°2 first at Visit 1, then, Training Protocol n°1 at Visit 2
Conditions studied
- Cochlear Nerve Deafness — all drugs for Cochlear Nerve Deafness →
- Cochlear Diseases — all drugs for Cochlear Diseases →
- Cochlear Hearing Loss — all drugs for Cochlear Hearing Loss →
- Hearing Loss — all drugs for Hearing Loss →
Sponsor
Hospices Civils de Lyon — full company profile →
Who can join
Adults 18 to 65, any sex, with Cochlear Nerve Deafness or Cochlear Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
We recently developed a new Neuro-immersion system based on virtual reality and 3D (dimension) motion tracking. This tool makes it possible to evaluate and record the spatial localization performance of sounds and to highlight localization deficits in the three dimensions of space in deaf patients. Unfortunately, there is currently no suitable support to compensate for these localization deficits. However, the discomfort felt by the patients is clearly verbalized. Thanks to the new virtual reality system, we are now able to develop a training protocol based on spatial sound localization tasks.
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
-
Adapting to altered auditory cues: Generalization from manual reaching to head pointing.
Valzolgher C, Todeschini M, Verdelet G, Gatel J, et al · · 2022 · cited 16× · PMID 35421095 · DOI 10.1371/journal.pone.0263509 -
Audiovisual Training in Virtual Reality Improves Auditory Spatial Adaptation in Unilateral Hearing Loss Patients.
Alzaher M, Valzolgher C, Verdelet G, Pavani F, et al · · 2023 · cited 12× · PMID 36983357 · DOI 10.3390/jcm12062357 -
Training spatial hearing in unilateral cochlear implant users through reaching to sounds in virtual reality.
Valzolgher C, Bouzaid S, Grenouillet S, Gatel J, et al · · 2023 · cited 6× · PMID 36905419 · DOI 10.1007/s00405-023-07886-1 -
Capturing Visual Attention With Perturbed Auditory Spatial Cues.
Valzolgher C, Alzaher M, Gaveau V, Coudert A, et al · · 2023 · PMID 37611181 · DOI 10.1177/23312165231182289
Verify or expand the search:
- PubMed search for NCT04183348
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Hospices Civils de Lyon trials
Trials by the same sponsor.
- NCT07569536 — Efficacy of the Alpha 2 Agonist Dexmedetomidine for Sympathetic Deactivation in REfractory Septic Shock · Phase 3 · not yet recruiting
- NCT07529314 — Evaluating Interventional Radiology for Cancer Pain Management · NA · not yet recruiting
- NCT07273929 — Comparative Study of the Effectiveness of Three Access Routes for Implanting an Electronic Intracardiac Device · Phase 3 · not yet recruiting
- NCT07474532 — Attitudes and Beliefs Related to Benzodiazepine Deprescribing · not yet recruiting
- NCT07313007 — Assessment of Gut Microbiota-Derived Amino Acid Metabolite Production in Patients With MASLD · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04183348 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospices Civils de Lyon
- Last refreshed: 3 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04183348.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing